:root{--dp-navy:#0d1b2a;--dp-slate:#1b263b;--dp-gold:#f4b400;--dp-gold-d:#c99400;--dp-ink:#14202e;--dp-mute:#5b6b7c;--dp-line:#e3e8ee;--dp-bg:#f6f8fa} body{color:var(--dp-ink)} a{color:var(--dp-navy)} .dp-spec{width:100%;border-collapse:collapse;margin:1.4em 0;font-size:.95rem} .dp-spec th,.dp-spec td{border:1px solid var(--dp-line);padding:.7rem .9rem;text-align:left;vertical-align:top} .dp-spec thead th{background:var(--dp-navy);color:#fff;font-weight:600;border-color:var(--dp-navy)} .dp-spec tbody th{background:var(--dp-bg);width:38%;font-weight:600} .dp-spec tbody tr:nth-child(even) td{background:#fbfcfd} .dp-compliance{background:#fff8e6;border:1px solid #f0d78a;border-left:5px solid var(--dp-gold);padding:1.1rem 1.3rem;margin:2em 0;border-radius:6px;font-size:.9rem;line-height:1.6} .dp-links{list-style:none;padding:0;margin:1em 0 2em;display:grid;grid-template-columns:repeat(auto-fit,minmax(240px,1fr));gap:.6rem} .dp-links li{margin:0} .dp-links a{display:block;padding:.75rem 1rem;border:1px solid var(--dp-line);border-radius:6px;background:#fff;text-decoration:none;transition:.15s} .dp-links a:hover{border-color:var(--dp-gold);background:#fffdf5} .dp-state-notice{background:#eef4fb;border:1px solid #cfe0f3;padding:.8rem 1rem;border-radius:6px;margin:0 0 1.2rem;font-size:.9rem} .dp-ship-bar{background:var(--dp-navy);color:#fff;padding:.7rem 1rem;border-radius:6px;margin:0 0 1.2rem;font-size:.9rem;text-align:center} .dp-ship-ok{background:#1c7a4b} #dp-age-gate{position:fixed;inset:0;background:rgba(9,17,26,.93);z-index:999999;display:flex;align-items:center;justify-content:center;padding:1.2rem} #dp-age-gate[hidden]{display:none} .dp-age-card{background:#fff;max-width:520px;width:100%;border-radius:10px;padding:2.2rem;text-align:center;box-shadow:0 20px 60px rgba(0,0,0,.4)} .dp-age-card h2{margin-top:0;color:var(--dp-navy)} .dp-age-fine{font-size:.8rem;color:var(--dp-mute);line-height:1.5} .dp-age-actions{display:flex;gap:.7rem;justify-content:center;flex-wrap:wrap;margin-top:1.4rem} #dp-age-yes{background:var(--dp-gold);color:var(--dp-navy);border:none;padding:.85rem 1.6rem;border-radius:6px;font-weight:700;cursor:pointer} #dp-age-yes:hover{background:var(--dp-gold-d)} .dp-btn-ghost{background:#fff;border:1px solid var(--dp-line);padding:.85rem 1.6rem;border-radius:6px;cursor:pointer} html.dp-locked body{overflow:hidden} .dp-accordion{margin:1.5em 0} .dp-faq-item{border:1px solid var(--dp-line);border-radius:6px;margin:0 0 .6rem;background:#fff;overflow:hidden} .dp-faq-item summary{cursor:pointer;padding:1rem 1.2rem;font-weight:600;list-style:none;display:flex;justify-content:space-between;align-items:center;gap:1rem} .dp-faq-item summary::-webkit-details-marker{display:none} .dp-faq-item summary:after{content:"+";font-size:1.4rem;color:var(--dp-gold-d);font-weight:400} .dp-faq-item[open] summary:after{content:"\2212"} .dp-faq-item[open] summary{background:var(--dp-bg);border-bottom:1px solid var(--dp-line)} .dp-faq-a{padding:.4rem 1.2rem 1.2rem} .dp-faq-permalink{text-decoration:none;color:var(--dp-mute);font-weight:400;opacity:.5} .dp-topic-index{list-style:none;padding:0;display:grid;grid-template-columns:repeat(auto-fit,minmax(220px,1fr));gap:.6rem} .dp-topic-index a{display:block;padding:.9rem 1.1rem;border:1px solid var(--dp-line);border-radius:6px;background:#fff;text-decoration:none} .dp-topic-index a:hover{border-color:var(--dp-gold)} .dp-count{color:var(--dp-mute);font-size:.85rem} .dp-post-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(260px,1fr));gap:1.2rem;margin:1.5em 0} .dp-post-card{border:1px solid var(--dp-line);border-radius:8px;padding:1.3rem;background:#fff} .dp-post-card h3{margin-top:0;font-size:1.05rem} .dp-post-card p{font-size:.9rem;color:var(--dp-mute)} .dp-related{border-top:2px solid var(--dp-line);margin-top:2.5em;padding-top:1.4em} .dp-related ul{list-style:none;padding:0;display:grid;grid-template-columns:repeat(auto-fit,minmax(230px,1fr));gap:.6rem} .dp-related a{text-decoration:none} .dp-related-cta{margin-top:1em;font-size:.9rem} .dp-hero{background:linear-gradient(135deg,var(--dp-navy),var(--dp-slate));color:#fff;padding:3.5rem 1.5rem;border-radius:10px;margin:0 0 2.5rem} .dp-hero h1{color:#fff;margin-top:0;font-size:2.3rem;line-height:1.2} .dp-hero p{color:#d5dde6;font-size:1.05rem;max-width:70ch} .dp-hero .dp-cta{display:inline-block;background:var(--dp-gold);color:var(--dp-navy);padding:.9rem 1.8rem;border-radius:6px;font-weight:700;text-decoration:none;margin-top:1rem} .dp-hero .dp-cta:hover{background:var(--dp-gold-d)} .dp-badges{display:flex;gap:1.4rem;flex-wrap:wrap;margin-top:1.6rem;font-size:.85rem} .dp-badges span{display:flex;align-items:center;gap:.4rem;color:#cfd8e2} .dp-badges b{color:var(--dp-gold)} .dp-strength-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(180px,1fr));gap:1rem;margin:1.8em 0} .dp-strength-card{border:1px solid var(--dp-line);border-radius:8px;padding:1.2rem;background:#fff;text-align:center} .dp-strength-card .n{font-size:1.6rem;font-weight:800;color:var(--dp-navy);display:block} .dp-strength-card a{display:block;margin-top:.6rem;font-weight:600;text-decoration:none} .dp-two-col{display:grid;grid-template-columns:1fr 1fr;gap:2rem;margin:2em 0} @media(max-width:720px){.dp-two-col{grid-template-columns:1fr}.dp-hero h1{font-size:1.7rem}} .dp-trust{background:var(--dp-bg);border-radius:8px;padding:1.6rem;margin:2em 0} .dp-trust ul{margin:0;padding-left:1.2rem} .dp-trust li{margin:.4rem 0}

What Schedule I Means — and Doesn’t — for 7-OH

“Schedule I” gets repeated in this space the way “FDA approved” gets repeated in supplement spaces — often without either side knowing what it means. Here is the plain-language version, applied specifically to the pending 7-OH question.

What Schedule I actually is

Schedule I of the Controlled Substances Act is the classification for substances the government has determined have (1) no currently accepted medical use in the U.S. and (2) a lack of accepted safety for use even under medical supervision, combined with a high potential for abuse. The practical effect of the classification is regulatory, not pharmacological: it subjects manufacture, distribution, import, export, research and possession of the substance to federal controls, with civil and criminal sanctions for violations. It does not change what the molecule does to a body, and it does not change state law in the short term (though it changes what states can do).

What it would change, specifically, for 7-OH

If the DEA’s pending temporary order issues and covers concentrated 7-OH (see the process timeline): selling, shipping and possessing above-threshold 7-OH products would become a federal matter with federal sanctions. For a buyer in a currently-legal state, the effect would not be “your state’s rule changed” — it would be that the federal floor rose under the state’s rule. The buyer-side scenarios post walks through what that means in practice, including what happens to orders already placed.

What it does not change

  • The substance’s effects or risks. 7-OH is what it is — a potent opioid-receptor-acting alkaloid — regardless of the label the government puts on it. The mechanism post and the side effects guide are true before and after any order.
  • Your personal history. Tolerance, routine and health context are not regulated. The responsible use guide continues to be the right frame.
  • Other products. The proposed order is specific to 7-OH above a threshold (and the separate, already-effective order to the three synthetic compounds). The state overview covers the rest of the landscape.

How to follow it without losing sleep

The Federal Register is the source of record. The compliance page mirrors it for this store’s customers, and the blog publishes a post when the order issues — with the practical buyer guidance attached, not just the headline. Until then, the current rules are the current rules, and we apply exactly those to every order.

Scroll to Top